Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
Lanreotide Autogel for the treatment of patients with Idiopathic Pulmonary Fibrosis (IPF) LANREOTIDE AUTOGEL NELTRATTAMENTO DEI PAZIENTI CON FIBROSI POLMONARE IDIOPATICA
To evaluate the use of Lanreotide Autogel for the treatment of patients with IPF. In particular, primary aim of the study is to assess whether Lanretoitde Autogel therapy is able to improve or stabili...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
CETUXIMAB IN COMBINATION WITH CISPLATIN PLUS DOCETAXEL TO EVALUATE THE ACTIVITY AND SAFETY IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA: PHASE II DOCETUX STUDY
ユ To investigate the efficacy and safety of Cetuximab in combination with Docetaxel plus Cisplatin in patients with locally advanced or metastatic gastric and gastroesophageal junction adenocarcinoma ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
SEQUENTIAL CHEMOTHERAPY WITH CISPLATIN PLUS VINORELBINE FOLLOWED BY WEEKLY DOCETAXEL IN LOCALLY ADVANCED OR METASTATIC NON SMALL-CELL LUNG CANCER
To determine time to disease progression of sequential chemotherapy with cisplatin plus vinorelbine followed by weekly docetaxel in patients with locally advanced or metastatic NSCLC not previously tr...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
A multi-centre, randomised study of Zoledronic Acid versus Observation in Patients with Asymptomatic Myeloma
To define the time to the first skeletal event in patients with asymptomatic myeloma treated or not with Zoledronic Acid 4 mg administered as 15-minute infusion every 4 weeks for at maximum 24 mon...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
Use of Bone Morphogenic Protein 7 in the atrophic maxilla
Implant survival and success, sinus lifted bone histologic and histomorphometic evaluation 4 month after surgery
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
THE EFFICACY OF DEXAMETHASONE IN MECHANICALLY VENTILATED CHILDREN WITH LOWER RESPIRATORY TRACT INFECTION CAUSED BY RESPIRATORY SYNCYTIAL VIRUS
To estimate the effectiveness of corticosteroids dexamethasone in mechanically ventilated children with Rsv-LTRI with classification of patients into the two clinical patterns of bronchiolitis and p...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
A Phase II Study exploring the feasibility of Azacitidine and Lenalidomide use (combination vs sequential treatment) for Higher-Risk Myelodysplastic Syndromes (MDS) (IPSS Risk: High or INT-2) Studio di fase II sulla fattibilita' dell’utilizzo di Azacitidina e Lenalidomide (somministrati in combinazione o sequenzialmente) per il trattamento delle Sindromi Mielodisplastiche (MDS) ad alto rischio (rischioIPSS alto o intermedio-2)
To evaluate the feasibility of the combination Azacitidine + Lenalidomide vs the sequential use of Azacitidine and Lenalidomide in high risk Myelodysplastic Syndromes (MDS) (IPSS score risk : High or ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
2004-000966-10-IT
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
LIPOSOMAL AMPHOTERICIN B (AMBISOME) 10 mg/kg once a week for 10 weeks as maintenance antifungal therapy for Proven/Probable Invasive Fungal Infection in hematologic patients with Acute Myeloid Leukaemia and/or in Allogeneic Hematopoietic Stem Cell Transplant recipients. AMFOTERICINA B liposomiale (Ambisome ) 10 mg/kg una volta alla settimana per 10 settimane come terapia di mantenimento per infezioni fungine invasive certe/probabilili in pazienti ematologici con leucemia mieloide acuta e/o in pazienti con trapianto di cellule staminali allogeniche
The main objective of the study is to assess the efficacy of 10 administrations of L-AmB 10 mg/kg once a week as maintenance antifungal therapy after 14 days of standard therapy with L-AmB 3 mg/kg onc...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
MAJ Il y a 4 ans
Pilot study on the short-term effects of Sildenafil on hemodynamic response to exercise and exercise capacity in Fontan patients
The present study sought to assess the short-term effects of sildenafil on cardiopulmonary function and on the response to exercise of pulmonary blood flow and cardiac output in Fontan patients
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Précédent
1
2
3
4
5
6
7
8
9
10
Suivant